艾滋病毒相关结核病的综合性审查:临床挑战和管理方面的进展
Aniket Patel1, Aditya Pundkar2, Anshu Agarwal1
1Emergency Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education & Research, Wardha, IND.
Cureus
|October 7, 2024
概括
人类免疫缺陷病毒 (HIV) 和结核病 (TB) 的联合感染给全球健康带来了重大挑战. 有效的管理需要综合治疗策略,改进的诊断和针对不同人群的量身定制方法,以减少发病率和死亡率.
科学领域:
- 全球健康 全球健康
- 传染性疾病 传染性疾病
- 临床医学 临床医学
背景情况:
- 人类免疫缺陷病毒 (HIV) 和结核病 (TB) 是全球发病率和死亡率的主要原因.
- 由于免疫抑制,艾滋病毒感染显著增加患有活跃结核病的风险.
- 艾滋病毒-结核病的同时感染在诊断和治疗方面带来了复杂的临床挑战.
研究的目的:
- 提供艾滋病毒相关结核病 (HIV-TB) 的综合分析.
- 专注于治疗艾滋病毒-结核病的临床挑战和进展.
- 综合当前的证据和临床实践,以改善患者护理.
主要方法:
- 审查当前的诊断方法和测试技术的进步.
- 检查综合治疗方案,包括抗逆转录病毒疗法 (ART) 和结核病治疗.
- 对弱势群体 (儿童,孕妇,老年人) 特别考虑的讨论.
主要成果:
- 艾滋病毒-结核病管理因药物相互作用,坚持问题和不良影响而复杂化.
- 诊断和综合治疗策略的进步对于更好的结果至关重要.
- 公共卫生战略和社会经济因素对疾病管理产生重大影响.
结论:
- 有效管理艾滋病毒-结核病需要一个多方面的方法.
- 持续的研究和创新对于改善共感染个体的结果至关重要.
- 应对共感染对于减少全球疾病负担至关重要.
相关概念视频
Pulmonary Tuberculosis V
170
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
170
Pulmonary Tuberculosis I
221
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
221
Pulmonary Tuberculosis IV
134
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
134
Pulmonary Tuberculosis II
213
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
213
Pulmonary Tuberculosis III
312
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
312
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K


